VOYA INVESTMENT MANAGEMENT LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1068837 ATLANTA, GA

Position in LCTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$48,773

+$31,298 QoQ

Shares Held

37,232

-4.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 130 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. LCTX ranks #183 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	TWST	Twist Bioscience Corp	671,866	$69,121,573
4	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
5	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
6	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
7	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
8	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,773	37,232	-4.1%	Shares	Defined	2026-08-12
2025-03-31	$17,475	38,835	0.0%	Shares	Defined	2025-06-18
2024-12-31	$19,417	38,835	-31.6%	Shares	Defined	2025-05-02
2024-09-30	$51,675	56,786	0.0%	Shares	Defined	2025-02-07
2024-06-30	$56,786	56,786	+18.7%	Shares	Defined	2025-02-07
2024-03-31	$70,788	47,830	-15.5%	Shares	Defined	2025-02-07
2023-12-31	$61,688	56,595	0.0%	Shares	Defined	2025-02-07
2023-09-30	$66,782	56,595	0.0%	Shares	Defined	2025-02-07
2023-06-30	$79,798	56,595	+19.6%	Shares	Defined	2025-02-07
2022-03-31	$72,865	47,315	0.0%	Shares	Defined	2022-05-16
2021-12-31	$115,921	47,315	-1.4%	Shares	Defined	2022-02-14
2021-09-30	$120,884	47,970	0.0%	Shares	Defined	2021-11-15
2021-06-30	$136,714	47,970	-19.1%	Shares	Defined	2021-08-16
2020-03-31	$49,238	59,324	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.